Trading at 75.8% below our estimate of its fair value
Earnings are forecast to grow 83.28% per year
Trading at good value compared to peers and industry
WBA stock is a strong buy due to its consistent dividend yield, robust global presence, and strategic initiatives in healthcare and retail. The company's expansion into digital health positions it for future growth.
Earnings are forecast to grow 83.28% per year
Trading at good value compared to peers and industry
WBA stock is a strong buy due to its consistent dividend yield, robust global presence, and strategic initiatives in healthcare and retail. The company's expansion into digital health positions it for future growth.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.